Strattera is the first non-stimulant drug, which the FDA has approved for use in treating Attention Deficit Hyperactivity Disorder (ADHD), and at first glance, that might have been a good...
I happened to read Tom Lamb’s article (Drug Injury Watch) this morning about Avandia. I learned that Public Citizen’s Health Research Group’s (HRG) has requested that the FDA ban...
The Yin: As the old saying goes, there are two sides to every story. Today, an article appeared in the Journal of the American Medical Association (JAMA) raising new concerns about a unexpected...
Keep up with the latest updates using your favorite RSS reader
Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.
Looking for an InjuryBoard attorney closer to home? Click here.